Procurement Summary
Country: Brazil
Summary: Acquisition of Ophthalmic Drugs for the Ophthalmology Clinic
Deadline: 22 Aug 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 124465730
Document Ref. No.: 90061/2025
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of Ophthalmic Medicines for the Ophthalmology Clinic
UASG Code: 160242
Notice from: 12/08/2025 from 09:00 to 11:30 and from 13:00 to 16:00
Proposal Delivery: From 12/08/2025 to 09:00
Atropine sulfate, dosage 10 mg/ml, use solution Ophthalmic
Quantity: 24
Trypan blue, 0.1%concentration, pharmaceutical form ophthalmic solution
Quantity: 600
Patent blue, concentration 2.5%, pharmaceutical form injectable solution
Quantity: 480
Betaxolol hydrochloride, 0.5%concentration, presentation ophthalmic solution
Quantity: 75
Bimatoprost, Dosage 0.3 mg/ml, presentation ophthalmic solution
Quantity: 95
BRIMINIDINA TARTARATO, DOSAGE 2 MG/ML, PRESENTATION COLILY
Carbacol, dosage 0.1 mg/ml, type use injectable intraocular solution
Quantity: 720
Sodium Carmelose, 5 mg/ml concentration, pharmaceutical form Ophthalmic
Quantity: 101
Cyclopentolate, 1%concentration, application ophthalmic solution
Quantity: 85
Ciprofloxacin hydrochloride, active ingredient associated with dexamethasone, dosage3.5 mg + 1 mg/g, pharmaceutical form ophthalmic ointment
Quantity: 90
Dexamethasone, dosage 0.1%, presentation solution Ophthalmic
Quantity: 89
Dexamethasone, 0.7 mg concentration, pharmaceutical form ophthalmic implantation, additional characteristics w/ application system
Quantity: 21
Ciprofloxacin hydrochloride, active ingredient associated with dexamethasone, dosage3.5 mg + 1 mg/ml, presentation ophthalmic solution
Amount : 62
Ciprofloxacin hydrochloride, dosage 3.5 mg/ml, pharmaceutical form ophthalmic solution
Quantity: 60
Ciprofloxacin hydrochloride, dosage 3.5 mg/g, ophthalmic pharmaceutical form
Dexpanthenol, concentration 50 mg/g, pharmaceutical form gel ophthalmic
Quantity: 46
Dextrana, Composition DExTRAIN 70 ASSOCIATED TO HYPROMELOSE, KNOW.
Documents
Tender Notice